Danske Bank’s bluebird bio BLUE Stock Holding History

Danske Bank’s Portfolio BLUE Stock Details BLUE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-10	Closed	-$83	–	1388
2024 Q4	$83	Buy	+10	New	+$87	﹤0.01%	1306

Other funds holding BLUE

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

TCM

Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

CIEC

Crédit Industriel et Commercial Paris France, France $1.55B AUM 42.08% 1-Year Est. Return

GLF

Groupe la Francaise Paris, France $7.29B AUM 37.28% 1-Year Est. Return

EPM

Equitec Proprietary Markets Chicago, Illinois $559M AUM 230.29% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

QOP

Quinn Opportunity Partners Charlottesville, Virginia $1.92B AUM 31.26% 1-Year Est. Return

Danske Bank's BLUE Position: Q1 2025 in Review

Danske Bank sold out of bluebird bio (BLUE) in Q1 2025, closing a stake of 10 shares — an estimated $83 sold.

Danske Bank first reported a position in BLUE in Q4 2024 and held it in 1 quarter. The position peaked at $83 in Q4 2024. 85 funds tracked by Wall St. Rank hold BLUE as of Q1 2025.

Danske Bank reported no remaining bluebird bio position as of Q1 2025 after selling out during the quarter.
Danske Bank sold 10 bluebird bio shares in Q1 2025, an estimated $83.
Danske Bank first reported a position in bluebird bio in Q4 2024 and held it in 1 quarter.
Danske Bank's bluebird bio position peaked at $83 in Q4 2024.
85 funds tracked by Wall St. Rank held bluebird bio as of Q1 2025.

Based on Danske Bank's 13F filing for Q1 2025, filed 18 Dec 2025.